Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-11-08 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −1,500 229,854
2021-09-27 Mills Kenneth T. President and CEO Option exercise +1,500 $3.76 $6K 282,484
2021-09-27 Mills Kenneth T. President and CEO Sale −1,500 $42.19 $63K 280,984
2021-09-27 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −1,500 231,354
2021-09-17 Fox Allan M. Director Sale −48,233 $45.04 $2.2M 1,364,309
2021-09-14 Mills Kenneth T. President and CEO Option exercise +33,146 $3.76 $125K 314,130
2021-09-14 Mills Kenneth T. President and CEO Option exercise +1,854 $0.85 $2K 315,984
2021-09-14 Mills Kenneth T. President and CEO Sale −35,000 $45.11 $1.6M 280,984
2021-09-14 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −33,146 232,854
2021-09-14 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −1,854 37,816
2021-09-13 Mills Kenneth T. President and CEO Option exercise +3,000 $3.76 $11K 283,984
2021-09-13 Mills Kenneth T. President and CEO Sale −3,000 $40.02 $120K 280,984
2021-09-13 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −3,000 266,000
2021-09-03 MIGAUSKY GEORGE V Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2021-09-03 Bennett Jean Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2021-07-27 Vasista Vittal Chief Financial Officer Option exercise +10,000 $0.85 $9K 123,640
2021-07-27 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −10,000 64,900
2021-06-30 Danos Olivier Chief Scientific Officer Grant or award +555 $33.02 $18K 19,598
2021-06-25 Mills Kenneth T. President and CEO Option exercise +1,500 $3.76 $6K 282,484
2021-06-25 Mills Kenneth T. President and CEO Sale −1,500 $40.25 $60K 280,984

Page 16 of 25 · 494 trades